To study outcomes with voriconazole therapy in immunocompetent individuals following maximal safe endoscopic resection in invasive aspergillosis of the anterior skull base.  Retrospective study of patients with chronic invasive aspergillosis including symptomatology, extent of disease, and response to voriconazole following maximal safe resection in immunocompetent individuals.  Tertiary care superspeciality referral center.  Ten consecutive patients of invasive aspergillosis of anterior skull base managed over a period of 2 years.  Symptom resolution with systemic voriconazole and radiologic evaluation following systemic antifungals as per predefined protocol.  Maximal safe resection via transnasal endoscopic route followed by systemic antifungals provides excellent outcomes in invasive skull base aspergillosis. Although liver and renal functions, besides visual acuity, need serial monitoring, voriconazole is well tolerated by our patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288116PMC
http://dx.doi.org/10.1055/s-0036-1585089DOI Listing

Publication Analysis

Top Keywords

invasive aspergillosis
16
skull base
16
aspergillosis anterior
12
anterior skull
12
immunocompetent individuals
8
maximal safe
8
safe resection
8
systemic antifungals
8
invasive
5
skull
4

Similar Publications

Article Synopsis
  • This meta-analysis examines the effectiveness and safety of combining echinocandins with standard antifungal treatments for invasive aspergillosis infection (IAI).
  • Ten studies with 1,100 patients were reviewed, comparing outcomes like clinical cure rates, mortality, and adverse drug reactions between combination therapy and standard monotherapy.
  • Results showed no significant differences in clinical cure rates or mortality between the two approaches, but there indicated a trend towards better outcomes for those receiving echinocandins alongside standard care, with similar safety profiles.
View Article and Find Full Text PDF

Chronic granulomatous disease (CGD) is a congenital disorder impairing phagocyte function, causing recurrent, life-threatening infections, and is rarely seen in adulthood. We present a 36-year-old male initially diagnosed with pneumonia. Bronchoalveolar lavage and blood cultures yielded complex, sputum cultures .

View Article and Find Full Text PDF

spp. are ubiquitous, and people are frequently exposed to their spores in the environment and hospital settings. Despite frequent inhalation of the spores, infection is infrequent in humans, except in immunosuppressed hosts.

View Article and Find Full Text PDF

Fungal infection in patients treated with Bruton's Tyrosine Kinase inhibitor, from epidemiology to clinical outcome: A systematic review.

Clin Microbiol Infect

December 2024

Sorbonne Université, CIMI-Paris, AP-HP, Service de Parasitologie-Mycologie, Hopital de La Pitie-Salpetriere, F-75013 Paris, France. Electronic address:

Background: Bruton Tyrosine Kinase inhibitor (BTKi) emerged as key treatment for B-cell lymphomas. Despite its efficacy in the treatment of malignancies, numerous cases of invasive fungal infections (IFI) have been reported in patients receiving ibrutinib, a first generation BTKi. Cases of invasive aspergillosis have also been reported with acalabrutinib and zanubrutinib.

View Article and Find Full Text PDF

A 12-year-old terrier was referred for investigation of a 4-month history of coughing, sneezing and nasal discharge. Clinical findings were consistent with sinonasal Aspergillus fumigatus infection with evidence of intracranial extension on computed tomography. Endoscopic debridement followed by topical clotrimazole and systemic antifungal therapy resulted in clinical improvement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!